{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:00:43Z","timestamp":1761562843227,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.carrev.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T02:08:43Z","timestamp":1594346923000},"page":"1128-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nicorandil for CIN Prevention \u2014 A Hope or Hype?"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-5929","authenticated-orcid":false,"given":"Yasir Abdul","family":"Ghaffar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-6997","authenticated-orcid":false,"given":"Ramesh","family":"Daggubati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.07.006_bb0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.carrev.2020.07.006_bb0010","first-page":"409","article-title":"Acute renal failure requiring dialysis after percutaneous coronary interventions","volume":"52","author":"Gruberg","year":"2001","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.07.006_bb0015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.07.006_bb0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ccd.20316","article-title":"Renal failure after percutaneous coronary intervention is associated with high mortality","volume":"64","author":"Gupta","year":"2005","journal-title":"Catheter Cardiovasc Interv [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCULATIONAHA.110.970160","article-title":"Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography","volume":"123","author":"James","year":"2011","journal-title":"Circulation [Internet]."},{"key":"10.1016\/j.carrev.2020.07.006_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/kisup.2012.3","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0035","first-page":"404","article-title":"Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study","volume":"19","author":"Ellis","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2020.07.006_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/1995-705X.125926","article-title":"Contrast-induced nephropathy","volume":"14","author":"Mohammed","year":"2013","journal-title":"Heart Views [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0045","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am J Kidney Dis [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0050","first-page":"e46","article-title":"Heart disease and stroke statistics\u20142010 update: a report from the American Heart Association","volume":"121","author":"Writing Group Members","year":"2010","journal-title":"Circulation [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0055","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0060","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2004.07.043","article-title":"Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction","volume":"44","author":"Marenzi","year":"2004","journal-title":"J Am Coll Cardiol [Internet]"},{"issue":"2","key":"10.1016\/j.carrev.2020.07.006_bb0065","article-title":"Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention","volume":"99","author":"Feldkamp","year":"2008","journal-title":"Minerva Med"},{"key":"10.1016\/j.carrev.2020.07.006_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ccd.1093","article-title":"Acute renal failure requiring dialysis after percutaneous coronary interventions","volume":"52","author":"Gruberg","year":"2001","journal-title":"Catheter Cardiovasc Interv [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3111\/200710119134","article-title":"Economic burden of contrast-induced nephropathy: implications for prevention strategies","volume":"10","author":"Subramanian","year":"2007","journal-title":"J Med Econ [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0080","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.07.006_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archinternmed.2011.1202","article-title":"Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction","volume":"172","author":"Amin","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.carrev.2020.07.006_bb0090","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-induced acute kidney injury","volume":"68","author":"McCullough","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.carrev.2020.07.006_bb0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5527\/wjn.v6.i3.86","article-title":"Contrast-induced acute kidney injury: a review of practical points","volume":"6","author":"Ozkok","year":"2017","journal-title":"World J Nephrol [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2011.06.115","article-title":"Pathophysiology of contrast-induced nephropathy","volume":"158","author":"Wong","year":"2012","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.carrev.2020.07.006_bb0105","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s00380-016-0809-y","article-title":"Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization","volume":"31","author":"Fan","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.carrev.2020.07.006_bb0110","doi-asserted-by":"crossref","first-page":"J18","DOI":"10.1016\/0002-9149(89)90200-2","article-title":"Nicorandil as a hybrid between nitrates and potassium channel activators","volume":"63","author":"Taira","year":"1989","journal-title":"Am J Cardiol [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0115","doi-asserted-by":"crossref","first-page":"F491","DOI":"10.1152\/ajprenal.00263.2007","article-title":"Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide","volume":"294","author":"Sun","year":"2008","journal-title":"Am J Physiol - Ren Physiol"},{"key":"10.1016\/j.carrev.2020.07.006_bb0120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1476-5381.2011.01231.x","article-title":"Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney","volume":"163","author":"Shimizu","year":"2011","journal-title":"Br J Pharmacol [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0003319716675720","article-title":"Effect of long-term administration of nicorandil on endothelial function of the radial artery in patients with angina undergoing transradial percutaneous coronary intervention","volume":"68","author":"Fan","year":"2017","journal-title":"Angiology [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.carrev.2020.01.010","article-title":"Nicorandil reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography\/intervention - systematic review and meta-analysis of randomized controlled trials including GRADE qualification","volume":"21","author":"Pranata","year":"2020","journal-title":"Cardiovasc Revasc Med [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/imj.13962","article-title":"Preventive effect of nicorandil on contrast-induced nephropathy: a meta-analysis of randomised controlled trials","volume":"48","author":"Li","year":"2018","journal-title":"Intern Med J [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0003319717732237","article-title":"Effect of nicorandil administration on preventing contrast-induced nephropathy: a meta-analysis","volume":"69","author":"Zhan","year":"2018","journal-title":"Angiology [Internet]."},{"key":"10.1016\/j.carrev.2020.07.006_bb0145","article-title":"Nicorandil for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials","volume":"36","author":"Ma","year":"2018","journal-title":"Cardiovasc Ther [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0150","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.18632\/oncotarget.23965","article-title":"Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0155","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/17512433.2018.1508342","article-title":"Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials","volume":"11","author":"Li","year":"2018","journal-title":"Expert Rev Clin Pharmacol [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2215\/CJN.02580607","article-title":"Prevention of contrast-induced nephropathy with volume expansion","volume":"3","author":"Weisbord","year":"2008","journal-title":"Clin J Am Soc Nephrol [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0165","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(14)60753-4","article-title":"Hydration in contrast-induced acute kidney injury","volume":"383","author":"Briguori","year":"2014","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0170","article-title":"Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis","volume":"12","author":"Navarese","year":"2017","journal-title":"PLoS One [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0175","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1159\/000503160","article-title":"Efficacy of oral nicorandil to prevent contrast-induced nephropathy in patients with chronic renal dysfunction undergoing an elective coronary procedure","volume":"44","author":"Fan","year":"2019","journal-title":"Kidney Blood Press Res [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/0003319719841733","article-title":"Preventive effects of nicorandil against contrast-induced nephropathy in patients with moderate renal insufficiency undergoing percutaneous coronary intervention","volume":"71","author":"Zhang","year":"2020","journal-title":"Angiology [Internet]."},{"key":"10.1016\/j.carrev.2020.07.006_bb0185","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MCA.0000000000000826","article-title":"Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention","volume":"31","author":"Zhang","year":"2020","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2020.07.006_bb0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.5603\/CJ.a2017.0028","article-title":"Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: a prospective randomized controlled trial","volume":"24","author":"Iranirad","year":"2017","journal-title":"Cardiol J"},{"key":"10.1016\/j.carrev.2020.07.006_bb0195","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3349\/ymj.2013.54.4.957","article-title":"Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE study)","volume":"54","author":"Ko","year":"2013","journal-title":"Yonsei Med J [Internet]"},{"key":"10.1016\/j.carrev.2020.07.006_bb0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2015.05.078","article-title":"Continuous intravenous infusion of nicorandil for 4hours before and 24hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function","volume":"195","author":"Nawa","year":"2015","journal-title":"Int J Cardiol [Internet]"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920304292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920304292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:18:06Z","timestamp":1761560286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920304292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1553838920304292"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.07.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicorandil for CIN Prevention \u2014 A Hope or Hype?","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}